Attached files
file | filename |
---|---|
EX-99.1 - Xtant Medical Holdings, Inc. | v211673_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): February 16, 2011
Bacterin International Holdings,
Inc.
|
(Exact
Name of Registrant as Specified in Its Charter)
|
Delaware
|
(State
or Other Jurisdiction of
Incorporation)
|
333-158426
|
20-5313323
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
600
Cruiser Lane
Belgrade,
Montana
|
59714
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
(406)
388-0480
|
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see
General Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01 Regulation FD
Disclosure.
A copy of a press release entitled
“Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic
Surgeons 2011 Annual Meeting February 15-19” is attached as Exhibit 99.1 and
incorporated herein. The information in this Item 7.01 and the
document attached as Exhibit 99.1 are being furnished and shall not be deemed
“filed” for purposes of Section 18 of the Securities and Exchange Act of 1934,
as amended (the “Exchange Act”), nor otherwise subject to the liabilities of
that section, nor incorporated by reference in any filing under the Securities
Act of 1933 or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
Item
9.01. Financial Statements and
Exhibits.
(d) Exhibits.
Exhibit
No
|
Description
|
|
99.1
|
Press
Release of Bacterin International Holdings, Inc., dated February 16, 2011
entitled “Bacterin International to Announce Launch of OsteoSponge®SC
at American Academy of Orthopedic Surgeons 2011 Annual Meeting February
15-19”
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: February 16, 2011 | BACTERIN INTERNATIONAL HOLDINGS, INC. | ||
|
By:
|
/s/ Guy S. Cook | |
Name: | Guy S. Cook | ||
Title: | President and Chief Executive Officer | ||
EXHIBIT
INDEX
99.1
|
Press
Release of Bacterin International Holdings, Inc., dated February 16, 2011
entitled “Bacterin International to Announce Launch of OsteoSponge®SC
at American Academy of Orthopedic Surgeons 2011 Annual Meeting February
15-19”
|